Zobrazeno 1 - 10
of 707
pro vyhledávání: '"W, Bruns"'
Autor:
Elsemieke te Linde, Laura J. E. Boots, Laura G. M. Daenen, Moniek A. de Witte, Anke H. W. Bruns
Publikováno v:
HemaSphere, Vol 6, Iss 11, p e793 (2022)
Externí odkaz:
https://doaj.org/article/4078c76d9b304540a8713581329b2a1d
Autor:
Kathryn S Hensley, Marlou J Jongkees, Daryl Geers, Corine H GeurtsvanKessel, Yvonne M Mueller, Virgil A S H Dalm, Grigorios Papageorgiou, Hanka Steggink, Alicja Gorska, Susanne Bogers, Jan G den Hollander, Wouter F W Bierman, Luc B S Gelinck, Emile F Schippers, Heidi S M Ammerlaan, Marc van der Valk, Marit G A van Vonderen, Corine E Delsing, Elisabeth H Gisolf, Anke H W Bruns, Fanny N Lauw, Marvin A H Berrevoets, Kim C E Sigaloff, Robert Soetekouw, Judith Branger, Quirijn de Mast, Adriana J J Lammers, Selwyn H Lowe, Rory D de Vries, Peter D Katsikis, Bart J A Rijnders, Kees Brinkman, Anna H E Roukens, Casper Rokx
Publikováno v:
PLoS Medicine, Vol 19, Iss 10, p e1003979 (2022)
BackgroundVaccines can be less immunogenic in people living with HIV (PLWH), but for SARS-CoV-2 vaccinations this is unknown. In this study we set out to investigate, for the vaccines currently approved in the Netherlands, the immunogenicity and reac
Externí odkaz:
https://doaj.org/article/9ad594b98b274203b73f9a4dbe6a6859
Autor:
Elsemieke te Linde, Laura Doornekamp, Katrijn C. P. Daenen, Eric C. M. van Gorp, Anke H. W. Bruns
Publikováno v:
Vaccines, Vol 11, Iss 3, p 686 (2023)
Background: Specific vaccines are indicated for immunocompromised patients (ICPs) due to their vulnerability to infections. Recommendation of these vaccines by healthcare professionals (HCPs) is a crucial facilitator for vaccine uptake. Unfortunately
Externí odkaz:
https://doaj.org/article/509e521995a54f69bc9c875654ff2d69
Autor:
F. A. Niessen, M. S. M. van Mourik, A. H. W. Bruns, R. A. P. Raijmakers, M. C. H. de Groot, T. van der Bruggen
Publikováno v:
Antimicrobial Resistance and Infection Control, Vol 9, Iss 1, Pp 1-10 (2020)
Abstract Introduction Current guidelines advocate empirical antibiotic treatment (EAT) in haematological patients with febrile neutropenia. However, the optimal duration of EAT is unknown. In 2011, we have introduced a protocol, promoting discontinua
Externí odkaz:
https://doaj.org/article/2d58bbe203374913877e97299efb0475
Autor:
Marlou J Jongkees, Daryl Geers, Kathryn S Hensley, Wesley Huisman, Corine H GeurtsvanKessel, Susanne Bogers, Lennert Gommers, Grigorios Papageorgiou, Simon P Jochems, Jan G den Hollander, Emile F Schippers, Heidi S M Ammerlaan, Wouter F W Bierman, Marc van der Valk, Marvin A H Berrevoets, Robert Soetekouw, Nienke Langebeek, Anke H W Bruns, Eliane M S Leyten, Kim C E Sigaloff, Marit G A van Vonderen, Corine E Delsing, Judith Branger, Peter D Katsikis, Yvonne M Mueller, Rory D de Vries, Bart J A Rijnders, Kees Brinkman, Casper Rokx, Anna H E Roukens
Publikováno v:
The Journal of Infectious Diseases, 227(5), 651-662. OXFORD UNIV PRESS INC
The Journal of Infectious Diseases, 227(5), 651-662. Oxford University Press
Jongkees, M J, Geers, D, Hensley, K S, Huisman, W, GeurtsvanKessel, C H, Bogers, S, Gommers, L, Papageorgiou, G, Jochems, S P, den Hollander, J G, Schippers, E F, Ammerlaan, H S M, Bierman, W F W, van der Valk, M, Berrevoets, M A H, Soetekouw, R, Langebeek, N, Bruns, A H W, Leyten, E M S, Sigaloff, K C E, van Vonderen, M G A, Delsing, C E, Branger, J, Katsikis, P D, Mueller, Y M, de Vries, R D, Rijnders, B J A, Brinkman, K, Rokx, C & Roukens, A H E 2023, ' Immunogenicity of an Additional mRNA-1273 SARS-CoV-2 Vaccination in People With HIV With Hyporesponse After Primary Vaccination ', The Journal of infectious diseases, vol. 227, no. 5, pp. 651-662 . https://doi.org/10.1093/infdis/jiac451
The Journal of infectious diseases, 227(5), 651-662. Oxford University Press
The Journal of Infectious Diseases, 227(5), 651-662. Oxford University Press
Jongkees, M J, Geers, D, Hensley, K S, Huisman, W, GeurtsvanKessel, C H, Bogers, S, Gommers, L, Papageorgiou, G, Jochems, S P, den Hollander, J G, Schippers, E F, Ammerlaan, H S M, Bierman, W F W, van der Valk, M, Berrevoets, M A H, Soetekouw, R, Langebeek, N, Bruns, A H W, Leyten, E M S, Sigaloff, K C E, van Vonderen, M G A, Delsing, C E, Branger, J, Katsikis, P D, Mueller, Y M, de Vries, R D, Rijnders, B J A, Brinkman, K, Rokx, C & Roukens, A H E 2023, ' Immunogenicity of an Additional mRNA-1273 SARS-CoV-2 Vaccination in People With HIV With Hyporesponse After Primary Vaccination ', The Journal of infectious diseases, vol. 227, no. 5, pp. 651-662 . https://doi.org/10.1093/infdis/jiac451
The Journal of infectious diseases, 227(5), 651-662. Oxford University Press
BackgroundThe COVIH study is a prospective coronavirus disease 2019 (COVID-19) vaccination study in 1154 people with HIV (PWH), of whom 14% showed reduced antibody levels after primary vaccination. We evaluated whether an additional vaccination boost
Autor:
Doreen G Te, Raa, Lina, van der Straten, Michel, van Gelder, Sabina, Kersting, Mark-David, Levin, Rogier, Mous, Hanneke M, van der Straaten, Marten R, Nijziel, Ellen, van der Spek, Eduardus F M, Posthuma, Hein P J, Visser, Marjolein, van der Klift, Koen, de Heer, Mar, Bellido, Jeanette K, Doorduijn, Anke H W, Bruns, Reinier A P, Raijmakers, Arnon P, Kater
Publikováno v:
HOVON CLL study group 2022, ' Diagnosis, treatment and supportive management of chronic lymphocytic leukemia : recommendations of the Dutch HOVON CLL working group ', Leukemia and Lymphoma, vol. 63, no. 10, pp. 2276-2289 . https://doi.org/10.1080/10428194.2022.2084731
Management of patients with chronic lymphocytic leukemia (CLL) is changing due to considerable advances in the therapeutic armamentarium, and new therapies will possibly continue to emerge in the near future. Therefore, the CLL working group of the D
Autor:
Laura G. M. Daenen, Jan-Tom van der Bruggen, Roos J. Leguit, Lotte E. van der Wagen, Anna van Rhenen, Herman F. Wunderink, Moniek A. de Witte, Anke H. W. Bruns, Jurgen Kuball
Publikováno v:
Bone Marrow Transplantation.
Autor:
Sammy Huygens, Albert Dunbar, Jochem B Buil, Corné H W Klaassen, Paul E Verweij, Karin van Dijk, Nick de Jonge, Jeroen J W M Janssen, Walter J F M van der Velden, Bart J Biemond, Aldert Bart, Anke H W Bruns, Pieter-Jan A Haas, Astrid M P Demandt, Guy Oudhuis, Peter von dem Borne, Martha T van der Beek, Saskia K Klein, Peggy Godschalk, Lambert F R Span, Douwe F Postma, Greetje A Kampinga, Johan Maertens, Katrien Lagrou, Toine Mercier, Ine Moors, Jerina Boelens, Dominik Selleslag, Marijke Reynders, Willemien Zandijk, Jeanette K Doorduijn, Jan J Cornelissen, Alexander F A D Schauwvlieghe, Bart J A Rijnders
Background Invasive aspergillosis (IA) by a triazole-resistant Aspergillus fumigatus is associated with high mortality. Real-time resistance detection will result in earlier initiation of appropriate therapy. Methods In a prospective study, we evalua
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af0735d4103e430ca112cc81cef6f969
https://hdl.handle.net/https://repository.ubn.ru.nl/handle/2066/294639
https://hdl.handle.net/https://repository.ubn.ru.nl/handle/2066/294639
Autor:
Anke H W Bruns, Jürgen Kuball, Roel J de Weijer, Nening M. Nanlohy, Debbie van Baarle, Gaby Smits, Michelle J M Janssen, Frans M. Verduyn Lunel, Reinier A P Raijmakers
Publikováno v:
Bone Marrow Transplantation. 56:2922-2928
Vaccination after hematopoietic stem cell transplantation (HSCT) is essential to protect high-risk patients against potentially lethal infections. Though multiple studies have evaluated vaccine specific responses, no comprehensive analysis of a compl
Autor:
Michelle J. M. Janssen, Anke H. W. Bruns, Frans M. Verduyn Lunel, Reinier A. P. Raijmakers, Roel J. de Weijer, Nening M. Nanlohy, Gaby P. Smits, Debbie van Baarle, Jürgen Kuball
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a202a50835990b444d1069c1214b3d67
http://hdl.handle.net/10029/625987
http://hdl.handle.net/10029/625987